Expert Insights
ETF Channels
ETF Strategist
Relative Value
Core Equity
Multi-Asset
Smart Beta
Tactical Allocation
Thematic Investing
Alternatives
Leveraged & Inverse
Disruptive Technology
Innovative ETFs
Equity ETF
Fixed Income
Retirement Income
Multi-Factor
Webcasts
Popular ETFs
SPY – SPDR S&P 500 ETF
VOO – Vanguard S&P 500 ETF
QQQ – PowerShares QQQ ETF
GLD – SPDR Gold Shares ETF
IVV – iShares Core S&P 500 ETF
EFA – iShares MSCI EAFE ETF
EEM – iShares MSCI Emerging Markets ETF
IEMG – iShares Core MSCI Emerging Markets ETF
VTI – Vanguard Total Stock Market ETF
GDX – VanEck Vectors Gold Miners ETF
XLF – Financial Select Sector SPDR Fund
VEA – Vanguard FTSE Developed Markets ETF
VTV – Vanguard Value ETF
Top 34 Gold ETFs
Top 34 Oil ETFs
Top 130 Commodity ETFs
Top 47 Hedge Fund ETFs
Top 57 Financials ETFs
Top 68 Inverse Equities ETFs
Top 56 High Yield Bond ETFs
ETF Education
Newsletter
New ETFs
ETF Ecosystem
Education Central
Video
Podcasts
ETF Playbook
biotech stocks
Featured
More Triple-Leveraged Biotech ETFs Come to Town
By
Todd Shriber
June 23, 2015
Featured
Preparing for Biotech ETF Retrenchment
By
Todd Shriber
June 5, 2015
Featured
A New Biotech ETF Could Challenge Established Rivals
By
Todd Shriber
June 3, 2015
Featured
New Leveraged Biotech ETF off to a Fast Start
By
Todd Shriber
June 2, 2015
Featured
Biotech Hedge Funds are hot, but Biotech ETFs are Hotter
By
Todd Shriber
May 29, 2015
Featured
An ETF for Hedge Funds’ Favorite Biotechs
By
Todd Shriber
May 27, 2015
Featured
Interesting Biotech ETF Additions on the Way
By
Tom Lydon
September 5, 2014
Featured
Biotech ETFs Look to Build on Hot August Returns
By
Tom Lydon
September 3, 2014
Featured
The Right ETF for Biotech Takeover Targets
By
Todd Shriber
January 16, 2014
X
